Meert; Theo Frans

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meert; Theo Frans.The latest application filed is for "use of mtki 1 for treating or preventing bone cancer".

Company Profile

0.2.8

Meert; Theo Frans - Boom BE
Meert; Theo Frans - Beerse BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Mtki 1 For Treating Or Preventing Bone Cancer App 20080213275 - FREYNE; Eddy Jean Edgard ; et al.	2008-09-04
Substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage Grant 7,390,822 - Janssens , et al. June 24, 2	2008-06-24
Novel Substituted 4-Phenyl-4[H-Imidazol-2-YL]-Piperidine Derivatived And Their Use As Selective Non-Peptide Delta Opioid Agonists App 20080096925 - Janssens; Frans Eduard ; et al.	2008-04-24
Novel Formulations For Opioid-Based Treatments Of Pain Comprising 1-(1,2-Disubstituted Piperidinyl)-4-Substituted Piperazine Derivatives App 20080070924 - Janssens; Frans Eduard ; et al.	2008-03-20
Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists Grant 7,282,508 - Janssens , et al. October 16, 2	2007-10-16
Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives as selective non-peptide delta opiod agonists with antidepressant and anxiolytic activity App 20060287345 - Steckler; Thomas Horst Wolfgang ; et al.	2006-12-21
Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives App 20060128721 - Janssens; Frans Eduard ; et al.	2006-06-15
Method for treating or preventing a neural disorder with a neurotrophic growth factor App 20060122135 - Gabriel Geerts; Hugo Alfons ; et al.	2006-06-08
Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage App 20050004170 - Janssens, Frans Eduard ; et al.	2005-01-06
Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists App 20040260096 - Janssens, Frans Eduard ; et al.	2004-12-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.